TTN and Duchenne muscular dystrophy: Notably, a different label-free MS-based proteomic approach comparing the urinary proteome of MD patients (DMD, BMD and limb-girdle MD) versus healthy subjects, identified titin fragments as the most promising urinary biomarker for MD screening [49].